Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1990 1
1993 2
1994 2
1995 1
1998 2
2000 2
2003 1
2004 1
2005 1
2006 1
2007 1
2008 4
2009 3
2010 2
2011 3
2012 4
2013 1
2014 5
2015 6
2016 7
2017 10
2018 6
2019 6
2020 4
2021 1
2022 10
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

PubMed for id: 859696

76 results

Results by year

Filters applied: . Clear all
Page 1
β-catenin cancer-enhancing genomic regions axis is involved in the development of fibrolamellar hepatocellular carcinoma.
Gulati R, Johnston M, Rivas M, Cast A, Kumbaji M, Hanlon MA, Lee S, Zhou P, Lake C, Schepers E, Min KW, Yoon JH, Karns R, Reid LM, Lopez-Terrada D, Timchenko L, Parameswaran S, Weirauch MT, Ranganathan S, Bondoc A, Geller J, Tiao G, Shin S, Timchenko N. Gulati R, et al. Hepatol Commun. 2022 Oct;6(10):2950-2963. doi: 10.1002/hep4.2055. Epub 2022 Aug 24. Hepatol Commun. 2022. PMID: 36000549 Free PMC article.
Novel protein kinase cAMP-Activated Catalytic Subunit Alpha (PRKACA) inhibitor shows anti-tumor activity in a fibrolamellar hepatocellular carcinoma model.
Toyota A, Goto M, Miyamoto M, Nagashima Y, Iwasaki S, Komatsu T, Momose T, Yoshida K, Tsukada T, Matsufuji T, Ohno A, Suzuki M, Ubukata O, Kaneta Y. Toyota A, et al. Biochem Biophys Res Commun. 2022 Sep 17;621:157-161. doi: 10.1016/j.bbrc.2022.07.008. Epub 2022 Jul 7. Biochem Biophys Res Commun. 2022. PMID: 35839742
A framework for fibrolamellar carcinoma research and clinical trials.
Dinh TA, Utria AF, Barry KC, Ma R, Abou-Alfa GK, Gordan JD, Jaffee EM, Scott JD, Zucman-Rossi J, O'Neill AF, Furth ME, Sethupathy P. Dinh TA, et al. Nat Rev Gastroenterol Hepatol. 2022 May;19(5):328-342. doi: 10.1038/s41575-022-00580-3. Epub 2022 Feb 21. Nat Rev Gastroenterol Hepatol. 2022. PMID: 35190728 Free PMC article. Review.
76 results